Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of berkeley lovelace jr ncpn1284341, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

Berkeley Lovelace Jr.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Do you have a news tip you want to share with our journalists? Visit NBC News Tips to learn more.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Do you have a news tip you want to share with our journalists? Visit NBC News Tips to learn more.


Latest from Berkeley Lovelace Jr.

FDA leadership shake-up continues with departure of top drug regulator

Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, according to a Department of Health and Human Services official
2d ago

Trump’s flavored vape push sparks backlash from some MAHA influencers and administration officials

The Trump administration’s moves to make flavored vapes more widely available have caused a splintering among some in the MAHA movement and some federal health officials.
2d ago

news

/

Politics News

news

/

Politics News

Free primary care for all: Democratic think tank pushes the party on new health policy

As Democrats look for a viable healthcare message ahead of the midterm elections, one well-connected think tank is pushing the party to embrace a new idea: free primary care for all Americans

Fight over fruit-flavored vapes pushed FDA chief to resign

Dr. Marty Makary’s final days leading the Food and Drug Administration were consumed by internal fights over the Trump administration’s policy prescriptions.

Cheaper generic Ozempic is coming soon — but not for Americans

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?

Dr. Marty Makary is out as FDA commissioner

Dr. Marty Makary resigned as commissioner of the Food and Drug Administration in the fourth high-profile departure of a member of the Trump administration this year.

FDA claims there’s no estrogen patch shortage as women struggle to get prescriptions filled

The FDA removed the black box warning from hormone replacement therapies late last year, and recently, the most insured type, the estrogen patch, has been in short supply amid a boom in the therapy’s popularity.

Trump weighs firing Dr. Marty Makary as FDA chief

President Donald Trump is considering firing Dr. Marty Makary after simmering frustration with his performance as FDA chief, a source familiar with the matter says.

Scientists are working on a hantavirus vaccine — but it’s likely years away

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

He pitched military service with a promise of lifetime healthcare. When he needed it, the system failed.

For more than a decade, Guy Shoemaker pitched military service to potential new recruits with one key promise: healthcare for life.“You’re going to have medical and dental for the rest of your life,” said Shoemaker, a retired Army sergeant first class and recruiter who spent a year in Afghanistan.
11d ago

Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.